[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370761-105":59,"doc-detail-370761-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unlocking-the-mitochondrial-functional-code-unraveling-the-pathogenesis-of-ovarian-cancer-and-innovative-targets-to-inhibit-malignant-behavior","Unlocking the mitochondrial functional code - unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior","","Ovarian cancer (OC) is a highly lethal gynecological malignancy whose risk is shaped by genetic background, age, reproductive history, parity, obesity status, and smoking. Mitochondria, central organelles in eukaryotic cells, strongly influence OC initiation and progression. Evidence links mitochondrial dysfunction to accelerated proliferation, increased invasiveness, metastasis capability, and therapy resistance. The review analyzes interactions between mitochondrial dysfunction and OC malignant traits, including regulation of mitochondrial function by genetic variations, regulatory factors, and the tumor microenvironment (TME). It also summarizes therapeutic strategies targeting mitochondrial dysfunction to inform clinical research and treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unlocking-the-mitochondrial-functional-code-unraveling-the-pathogenesis-of-ovarian-cancer-and-innovative-targets-to-inhibit-malignant-behavior/370761/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unlocking-the-mitochondrial-functional-code-unraveling-the-pathogenesis-of-ovarian-cancer-and-innovative-targets-to-inhibit-malignant-behavior/370761.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What factors influence the risk of ovarian cancer mentioned in the review?","Question",{"text":112,"@type":113},"The review states that risk is influenced by genetic background, age, reproductive history, parity, obesity status, and smoking habits.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does mitochondrial dysfunction affect ovarian cancer progression?",{"text":117,"@type":113},"Mitochondrial dysfunction is linked to increased proliferation, invasiveness, metastasis ability, and resistance to therapy in ovarian cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review focus on regarding therapeutic targets?",{"text":121,"@type":113},"It summarizes therapeutic strategies that target mitochondrial dysfunction in ovarian cancer and aims to provide novel insights for clinical research and treatment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370761,1790210929,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Li et al. Journal of Translational Medicine (2025) 23:819  \n[https://doi.org/10.1186/s12967-025-06840-5](https://doi.org/10.1186/s12967-025-06840-5)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nUnlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior  \nChen-Yu Li 1 , Dan-Ni Ding 1, Ying Guo2, Yang Fu2, Ying Shen2, Jiang-Mei Fu3, Cheng-Xin Zhang4 and Feng-Juan Han2*  \nAbstract  \nThis article focuses on ovarian cancer (OC), the most lethal gynecological malignancy, whose risk is influenced by multiple factors, including genetic background, age, reproductive history, parity, obesity status, and smoking habits. Mitochondria, as the core organelles in eukaryotic cells, play a pivotal role in the initiation and progression of OC. In recent years, growing evidence has revealed a close relationship between mitochondrial dysfunction and the accelerated proliferation, enhanced invasiveness, metastasis ability, and therapy resistance of OC. This paper provides an in-depth analysis of the complex interactions between mitochondrial dysfunction and the malignant biological characteristics of OC, as well as the underlying regulatory mechanisms of mitochondrial function. Furthermore, it elaborates on how genetic variations, regulatory factors, and the tumor microenvironment (TME) influence mitochondrial function and drive the malignant progression of OC. Additionally, this paper comprehensively summarizes therapeutic strategies targeting mitochondrial dysfunction in OC, aiming to provide novel insights and strategies for clinical research and treatment.  \nKeywords Mitochondrial dysfunction, OC, Malignant biological behavior, Pathogenesis, Cancer therapy  \nIntroduction  \nDespite significant efforts by the medical community, OC remains a highly prevalent and lethal malignancy in women, with the highest mortality rate among  \n*Correspondence:  \nFeng-Juan Han [hanfengjuan2004@163.com](hanfengjuan2004@163.com)  \n1 Department of Obstetrics and Gynecology, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, China  \n2 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang, China  \n3 Department of Vascular Surgery, Wenshang County Traditional Chinese Medicine Hospital, Jining 272000, Shandong, China  \n4 Department of Preventive Medicine, Wenshang County Traditional Chinese Medicine Hospital, Jining 272000, Shandong, China  \ngynecological cancers and a persistently high incidence rate [1]. In 2022, 57,090 new OC cases were diagnosed, and 39,306 patients succumbed to the disease [2]. Due to the limited specificity of diagnostic biomarkers such as CA125 and HE4, as well as the absence of distinctive symptoms, approximately two-thirds of patients are diagnosed at an advanced stage, when the tumor has already spread to the extrapelvic peritoneum (FIGO stage III) or metastasized distantly (FIGO stage IV) [3, 4]. Most ovarian malignancies arise from epithelial cells, with highgrade tumors accounting for over 70% of cases. Despite advancements in cytoreductive surgery and the implementation of platinum-based/paclitaxel (PTX) chemotherapy, OC patients continue to face challenges such as high recurrence rates and chemoresistance to standard  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included ","cbCaiiLgeiJaHYZA","https://ap.wps.com/l/cbCaiiLgeiJaHYZA","pdf",3867212,"English","# Abstract\n# Introduction","[{\"question\":\"What factors influence the risk of ovarian cancer mentioned in the review?\",\"answer\":\"The review states that risk is influenced by genetic background, age, reproductive history, parity, obesity status, and smoking habits.\"},{\"question\":\"How does mitochondrial dysfunction affect ovarian cancer progression?\",\"answer\":\"Mitochondrial dysfunction is linked to increased proliferation, invasiveness, metastasis ability, and resistance to therapy in ovarian cancer.\"},{\"question\":\"What does the review focus on regarding therapeutic targets?\",\"answer\":\"It summarizes therapeutic strategies that target mitochondrial dysfunction in ovarian cancer and aims to provide novel insights for clinical research and treatment.\"}]","Unlocking the mitochondrial functional code - unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior | PDF",1790190250,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdbd5c652dcc5eebbe98b5b27ec5d62b.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4a39cac87baec06b436fc58ce7d02dc.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5783e5d9d46a2ac52ad11509449db209.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8a65c6aeaded95da2c3abee47a8e3ba.webp",980,1301]